In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 1072-67-9, name is 5-Methylisoxazol-3-amine, introducing its new discovery. Application In Synthesis of 5-Methylisoxazol-3-amine
Compounds of the formula: SPC1 Are disclosed. In the above formula, R1 is aryl such as benzene or a heterocycle such as pyridine, isoxazole, or thiazole. The aryl or heterocyclic group R1 is substituted or unsubstituted. R2 is hydrogen, lower alkyl, halogen, lower alkoxy, trifluoromethyl and the like. These compounds are useful as anti-inflammatory agents indicated in conditions such as rheumatoid arthritis.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 1072-67-9, and how the biochemistry of the body works.Application In Synthesis of 5-Methylisoxazol-3-amine
Reference：
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem